Stock Market

NCLT rejects Sun Pharma’s plan to demerge overseas subsidiary

The decision was approved by the Sun Pharma board in May 2018.

from Markets-Economic Times https://ift.tt/2tk01Hq

No comments

Powered by Blogger.